Aprea Therapeutics
aprea.com
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$3.1M
2 rounds on record
Latest round
$3.1M
Venture round · Dec 2025 · 10 mo ago
Grants
$2M
1 grant · CORDIS
Backers
1
HealthCap
The money's age
Fresh money
10 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2025 | $3.1M | — | SEC Form D |
| Grant | Feb 2023 | $2M | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | Aprea Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
John HamillExecutive OfficerSEC Form D
Oren GiladExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
HealthCap People
John Hamill
Executive Officer
Oren Gilad
Executive Officer, Director
Jean-Pierre Bizzari
Director
Gabriela Gruia
Director
Rifat Pamukcu
Director
Bernd Seizinger
Director
Marc Duey
Director
John Henneman
Director
Michael Grissinger
Director
Richard Peters
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Doylestown
United States
HQ